Ningbo Eye Hospital
7
0
3
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Auricular Acupressure Reduces Rebound Effects After Discontinuation of Atropine
Role: lead
OSPM-Enhanced AI Model to Identify Premalignant and Malignant Ocular Surface Tumors
Role: lead
Early Combined Use of Dexamethasone Intravitreal Implant and Anti-VEGF in the Treatment of DME.
Role: collaborator
Comparing Myopia Control Efficacy in Children With 4 Methods: Orthokeratology, DIMS, DISK, and SVS.
Role: collaborator
Evaluation of Diabetic Retinopathy Using Ultra-Widefield Fundus Images Compared With Two-Field Fundus Images
Role: lead
Sustained Effect of Red-light Therapy for Myopia Control: A 2-Year Post-Trial Follow-up Study
Role: collaborator
Deep Learning for the Discrimination Among Different Types of Keratits: a Nationwide Study
Role: lead
All 7 trials loaded